Tfo Tdc, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Tfo Tdc, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$902.69 - $993.35 $1.06 Million - $1.16 Million	-1,169 Reduced 99.91%	1 $0
Q4 2023 Feb 12, 2024	BUY	$775.18 - $881.7 $905,410 - $1.03 Million	1,168 Added 58400.0%	1,170 $1.03 Million
Q3 2023 Nov 02, 2023	BUY	$692.45 - $844.37 $692 - $844	1 Added 100.0%	2 $1,000
Q1 2023 May 03, 2023	SELL	$680.49 - $826.97 $5,443 - $6,615	-8 Reduced 88.89%	1 $0
Q4 2022 Feb 03, 2023	BUY	$705.89 - $766.39 $6,353 - $6,897	9 New	9 $6,000
Q2 2022 Jul 18, 2022	BUY	$548.35 - $738.84 $4,386 - $5,910	8 New	8 $5,000

1,529

84.1M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $81.1B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Tfo Tdc, LLC, based on Form 13F filings with the SEC.

Stay updated on Tfo Tdc, LLC with notifications on news.